Skip to main content
MEDICALSYSTEM BIOTECHNOLOGY CO., LTD logo

MEDICALSYSTEM BIOTECHNOLOGY CO., LTD — Investor Relations & Filings

Ticker · 300439 ISIN · CNE100001Z25 LEI · 3003007XTAWFVR8ASC23 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 1,715 across all filing types
Latest filing 2025-03-03 Regulatory Filings
Country CN China
Listing Shenzhen Stock Exchange 300439

About MEDICALSYSTEM BIOTECHNOLOGY CO., LTD

https://www.nbmksw.com

MedicalSystem Biotechnology Co., Ltd. specializes in the research, development, production, and distribution of in vitro diagnostic (IVD) products. The company offers a comprehensive portfolio that includes biochemical reagents, chemiluminescence immunoassay systems, molecular diagnostic kits, and point-of-care testing (POCT) solutions. Its product line covers a wide range of clinical applications such as liver function, kidney function, blood lipids, and cardiovascular markers. MedicalSystem is recognized for its integrated business model, which combines the manufacturing of high-quality diagnostic instruments with a vast array of compatible reagents. Additionally, the company provides third-party medical laboratory services to healthcare institutions. By focusing on technological innovation and standardized production, MedicalSystem supports clinical laboratories in achieving accurate and efficient diagnostic results for improved patient care.

Recent filings

Filing Released Lang Actions
关于公司及控股子公司取得医疗器械注册证的公告
Regulatory Filings Classification · 95% confidence The document is a company announcement regarding the acquisition of medical device registration certificates by the company and its subsidiary. It includes details about the certificates, their validity, and the expected impact on company performance. The document is short (1062 characters) and does not contain financial statements, detailed financial analysis, or regulatory certifications. It is an announcement of a regulatory approval event rather than a financial report or management discussion. Therefore, it fits best under Regulatory Filings (RNS) as a general regulatory announcement that does not fit other specific categories.
2025-03-03 Chinese
关于公司取得医疗器械注册证的公告
Regulatory Filings Classification · 95% confidence The document is a company announcement regarding the acquisition of a medical device registration certificate issued by a regulatory authority (Zhejiang Provincial Drug Administration). It includes details about the certificate, product, and its expected impact on the company. The document is short (830 characters) and does not contain financial statements or detailed financial data. It is an announcement of a regulatory approval rather than a financial report or management discussion. Therefore, it fits best under Regulatory Filings (RNS), which covers general regulatory announcements and compliance documents that do not fit other categories.
2025-01-09 Chinese
关于两家全资子公司获得高新技术企业证书的公告
Regulatory Filings Classification · 95% confidence The document is a company announcement regarding two wholly-owned subsidiaries receiving High-Tech Enterprise Certificates. It includes details about the certificates, issuing authorities, validity periods, and the tax benefits associated with the certification. There is no financial data, no mention of annual or quarterly reports, no voting results, no management changes, no legal proceedings, or other report types. The document is a formal announcement of a corporate event related to certification and tax status, which does not fit into financial reports or other specific categories. It is a regulatory announcement informing investors about a corporate development. Therefore, the most appropriate classification is Regulatory Filings (RNS). The document length is short and it is not a report publication announcement or certification letter, so RNS is the best fit.
2025-01-06 Chinese
关于公司取得医疗器械注册证的公告
Regulatory Filings Classification · 95% confidence The document is a company announcement regarding the acquisition of a medical device registration certificate issued by a regulatory authority (Zhejiang Provincial Drug Administration). It includes details about the certificate, product names, registration numbers, validity periods, and expected uses. The document also discusses the potential impact on company performance and includes a risk warning. The document is short (1016 characters) and is an announcement of a regulatory approval rather than a financial report or detailed management discussion. It does not contain financial statements, earnings data, or management analysis. It is not a report publication announcement since it does not mention the release of a report. It is a regulatory announcement about a certificate obtained, which fits best under Regulatory Filings (RNS) as a general regulatory announcement that does not fit other specific categories.
2024-12-27 Chinese
关于注销子公司伯明翰美康的公告
Regulatory Filings Classification · 95% confidence The document is an official announcement from 美康生物科技股份有限公司 regarding the cancellation (dissolution) of its subsidiary 伯明翰美康 (VAP DIAGNOSTICS LABORATORY INC). It includes background information on the subsidiary, financial data for recent periods, the decision process for the cancellation, and the impact of this cancellation on the parent company. The document references regulatory compliance and approvals but does not contain comprehensive financial statements or detailed financial performance analysis typical of annual or interim reports. It is a corporate announcement about a structural change (subsidiary dissolution) rather than a financial report or earnings release. Therefore, it fits best into the category of Regulatory Filings (RNS), which covers general regulatory announcements and compliance documents that do not fit other specific categories.
2024-12-27 Chinese
关于公司取得医疗器械注册证的公告
Regulatory Filings Classification · 95% confidence The document is a company announcement regarding the acquisition of medical device registration certificates issued by regulatory authorities (National Medical Products Administration and Zhejiang Provincial Medical Products Administration). It details the registration certificates obtained for various diagnostic reagent kits, their registration numbers, validity periods, and intended uses. The document also includes a statement on the impact of these certificates on the company's business and a risk warning. There are no financial statements, earnings data, or detailed financial analysis present. The document is a regulatory announcement about a non-financial event (product registration certificates) rather than a financial report or management discussion. It does not fit into categories like Annual Report, Earnings Release, or Management Reports. It is not a report publication announcement or certification letter. Therefore, the most appropriate classification is Regulatory Filings (RNS), which covers general regulatory announcements and compliance documents that do not fit other specific categories.
2024-12-20 Chinese

Browse filings by year

12 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.